E
Burcon Nutrascience Corporation
BU.TO
TSX
E
Sell
3/14/2023Downgrade
Burcon Nutrascience Corporation (BU.TO) was downgraded to E+ from D- on 03/14/2023.
Burcon Nutrascience Corporation (BU.TO) was downgraded to E+ from D- on 03/14/2023.
D
Sell
2/15/2023Upgraded
Burcon Nutrascience Corporation (BU.TO) was upgraded to D- from E+ on 2/15/2023 due to an increase in the growth index, total return index and volatility index. Total revenue increased 38.14% from $86 to $118.8, operating cash flow increased 22.59% from -$1.22M to -$943.2, and EBIT increased 12.17% from -$1.5M to -$1.31M.
Burcon Nutrascience Corporation (BU.TO) was upgraded to D- from E+ on 2/15/2023 due to an increase in the growth index, total return index and volatility index. Total revenue increased 38.14% from $86 to $118.8, operating cash flow increased 22.59% from -$1.22M to -$943.2, and EBIT increased 12.17% from -$1.5M to -$1.31M.
E
Sell
2/8/2023Downgrade
Burcon Nutrascience Corporation (BU.TO) was downgraded to E+ from D- on 2/8/2023 due to a decline in the solvency index, total return index and volatility index. The quick ratio declined from 2.35 to 1.71.
Burcon Nutrascience Corporation (BU.TO) was downgraded to E+ from D- on 2/8/2023 due to a decline in the solvency index, total return index and volatility index. The quick ratio declined from 2.35 to 1.71.
D
Sell
7/25/2022Downgrade
Burcon Nutrascience Corporation (BU.TO) was downgraded to D- from D on 7/25/2022 due to a substantial decline in the total return index, growth index and volatility index. Earnings per share declined from -$0.011 to -$0.0306, EBIT declined 121.14% from -$1.11M to -$2.46M, and operating cash flow declined 68.81% from -$1M to -$1.7M.
Burcon Nutrascience Corporation (BU.TO) was downgraded to D- from D on 7/25/2022 due to a substantial decline in the total return index, growth index and volatility index. Earnings per share declined from -$0.011 to -$0.0306, EBIT declined 121.14% from -$1.11M to -$2.46M, and operating cash flow declined 68.81% from -$1M to -$1.7M.
D
Sell
11/9/2021Upgraded
Burcon Nutrascience Corporation (BU.TO) was upgraded to D from E+ on 11/9/2021 due to an increase in the total return index.
Burcon Nutrascience Corporation (BU.TO) was upgraded to D from E+ on 11/9/2021 due to an increase in the total return index.
E
Sell
11/8/2021Downgrade
Burcon Nutrascience Corporation (BU.TO) was downgraded to E+ from D on 11/8/2021 due to a significant decline in the total return index, efficiency index and volatility index. Net income declined 30.76% from -$1.98M to -$2.59M, and total capital declined 6.07% from $28.86M to $27.11M.
Burcon Nutrascience Corporation (BU.TO) was downgraded to E+ from D on 11/8/2021 due to a significant decline in the total return index, efficiency index and volatility index. Net income declined 30.76% from -$1.98M to -$2.59M, and total capital declined 6.07% from $28.86M to $27.11M.
D
Sell
2/17/2021Downgrade
Burcon Nutrascience Corporation (BU.TO) was downgraded to D from D+ on 2/17/2021 due to a large decline in the growth index, total return index and efficiency index. Operating cash flow declined 129.95% from -$548.3 to -$1.26M, earnings per share declined from $0.03 to -$0.0077, and net income declined 125.36% from $3.29M to -$833.2.
Burcon Nutrascience Corporation (BU.TO) was downgraded to D from D+ on 2/17/2021 due to a large decline in the growth index, total return index and efficiency index. Operating cash flow declined 129.95% from -$548.3 to -$1.26M, earnings per share declined from $0.03 to -$0.0077, and net income declined 125.36% from $3.29M to -$833.2.
D
Sell
11/17/2020Upgraded
Burcon Nutrascience Corporation (BU.TO) was upgraded to D+ from D on 11/17/2020 due to a substantial increase in the total return index, solvency index and efficiency index. Net income increased 424.92% from -$1.01M to $3.29M, debt to equity declined from 0.27 to 0, and the quick ratio increased from 5.45 to 8.99.
Burcon Nutrascience Corporation (BU.TO) was upgraded to D+ from D on 11/17/2020 due to a substantial increase in the total return index, solvency index and efficiency index. Net income increased 424.92% from -$1.01M to $3.29M, debt to equity declined from 0.27 to 0, and the quick ratio increased from 5.45 to 8.99.
D
Sell
5/1/2020Downgrade
Burcon Nutrascience Corporation (BU.TO) was downgraded to D from D+ on 5/1/2020 due to a significant decline in the efficiency index.
Burcon Nutrascience Corporation (BU.TO) was downgraded to D from D+ on 5/1/2020 due to a significant decline in the efficiency index.
D
Sell
2/18/2020Upgraded
Burcon Nutrascience Corporation (BU.TO) was upgraded to D+ from D on 2/18/2020 due to a significant increase in the efficiency index, total return index and volatility index. Total capital increased 78.01% from $8.68M to $15.45M.
Burcon Nutrascience Corporation (BU.TO) was upgraded to D+ from D on 2/18/2020 due to a significant increase in the efficiency index, total return index and volatility index. Total capital increased 78.01% from $8.68M to $15.45M.
D
Sell
11/15/2019Upgraded
Burcon Nutrascience Corporation (BU.TO) was upgraded to D from D- on 11/15/2019 due to a significant increase in the solvency index, growth index and total return index. Earnings per share increased from -$0.0212 to -$0.006, operating cash flow increased 49.55% from -$863.1 to -$435.4, and EBIT increased 29.36% from -$821.4 to -$580.2.
Burcon Nutrascience Corporation (BU.TO) was upgraded to D from D- on 11/15/2019 due to a significant increase in the solvency index, growth index and total return index. Earnings per share increased from -$0.0212 to -$0.006, operating cash flow increased 49.55% from -$863.1 to -$435.4, and EBIT increased 29.36% from -$821.4 to -$580.2.
D
Sell
7/3/2019Downgrade
Burcon Nutrascience Corporation (BU.TO) was downgraded to D- from D on 7/3/2019 due to a large decline in the solvency index, growth index and efficiency index. Debt to equity increased from -3.21 to -1.65, the quick ratio declined from 0.23 to 0.14, and total capital declined 23.16% from $1.23M to $943.2.
Burcon Nutrascience Corporation (BU.TO) was downgraded to D- from D on 7/3/2019 due to a large decline in the solvency index, growth index and efficiency index. Debt to equity increased from -3.21 to -1.65, the quick ratio declined from 0.23 to 0.14, and total capital declined 23.16% from $1.23M to $943.2.
D
Sell
4/15/2019Upgraded
Burcon Nutrascience Corporation (BU.TO) was upgraded to D from D- on 4/15/2019 due to an increase in the total return index and volatility index.
Burcon Nutrascience Corporation (BU.TO) was upgraded to D from D- on 4/15/2019 due to an increase in the total return index and volatility index.
D
Sell
2/15/2019Upgraded
Burcon Nutrascience Corporation (BU.TO) was upgraded to D- from E+ on 2/15/2019 due to an increase in the valuation index, growth index and efficiency index. Total revenue increased 87.72% from $5.7 to $10.7, operating cash flow increased 12.84% from -$766.5 to -$668.1, and earnings per share increased from -$0.0227 to -$0.0199.
Burcon Nutrascience Corporation (BU.TO) was upgraded to D- from E+ on 2/15/2019 due to an increase in the valuation index, growth index and efficiency index. Total revenue increased 87.72% from $5.7 to $10.7, operating cash flow increased 12.84% from -$766.5 to -$668.1, and earnings per share increased from -$0.0227 to -$0.0199.
E
Sell
8/3/2017Downgrade
Burcon Nutrascience Corporation (BU.TO) was downgraded to E+ from D- on 8/3/2017 due to a major decline in the total return index, solvency index and growth index. Total revenue declined 70.35% from $22.6 to $6.7, debt to equity increased from 0.34 to 0.45, and the quick ratio declined from 9.14 to 6.81.
Burcon Nutrascience Corporation (BU.TO) was downgraded to E+ from D- on 8/3/2017 due to a major decline in the total return index, solvency index and growth index. Total revenue declined 70.35% from $22.6 to $6.7, debt to equity increased from 0.34 to 0.45, and the quick ratio declined from 9.14 to 6.81.
D
Sell
2/10/2017Upgraded
Burcon Nutrascience Corporation (BU.TO) was upgraded to D- from E+ on 2/10/2017 due to a substantial increase in the solvency index, growth index and valuation index. The quick ratio increased from 2.59 to 9.14, debt to equity declined from 1.29 to 0.34, and total revenue increased 66.18% from $13.6 to $22.6.
Burcon Nutrascience Corporation (BU.TO) was upgraded to D- from E+ on 2/10/2017 due to a substantial increase in the solvency index, growth index and valuation index. The quick ratio increased from 2.59 to 9.14, debt to equity declined from 1.29 to 0.34, and total revenue increased 66.18% from $13.6 to $22.6.
E
Sell
1/20/2017Downgrade
Burcon Nutrascience Corporation (BU.TO) was downgraded to E+ from D- on 1/20/2017 due to a substantial decline in the solvency index, volatility index and valuation index. Debt to equity increased from 0.66 to 1.29, and the quick ratio declined from 4.52 to 2.59.
Burcon Nutrascience Corporation (BU.TO) was downgraded to E+ from D- on 1/20/2017 due to a substantial decline in the solvency index, volatility index and valuation index. Debt to equity increased from 0.66 to 1.29, and the quick ratio declined from 4.52 to 2.59.
D
Sell
3/11/2016Downgrade
Burcon Nutrascience Corporation (BU.TO) was downgraded to D- from D on 3/11/2016 due to a large decline in the volatility index, total return index and valuation index.
Burcon Nutrascience Corporation (BU.TO) was downgraded to D- from D on 3/11/2016 due to a large decline in the volatility index, total return index and valuation index.
